Reaction
Device Placement Issue reporting signals
As of the last recalculation, Device Placement Issue appears in 3,075 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is COPPER (PRR 352.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Copper | 1,300 | 352.9 | 363.9 |
| Etonogestrel | 795 | 151.7 | 154.3 |
| Pegfilgrastim | 198 | 14.4 | 14.5 |
| Levonorgestrel | 347 | 13.0 | 13.0 |
| Ketoprofen | 19 | 9.9 | 9.9 |
| Misoprostol | 12 | 8.4 | 8.4 |
| Amitriptyline Hydrochloride | 18 | 7.0 | 7.0 |
| Treprostinil | 97 | 5.4 | 5.4 |
| Amantadine | 12 | 5.3 | 5.3 |
| Rotigotine | 11 | 5.2 | 5.2 |
| Levodopa | 9 | 5.1 | 5.1 |
| Carbidopa And Levodopa | 32 | 4.6 | 4.6 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate | 22 | 4.2 | 4.2 |
| Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate | 23 | 3.8 | 3.8 |
| Rivastigmine | 10 | 3.6 | 3.6 |
| Rasagiline Mesylate | 5 | 3.0 | 3.0 |
| Macitentan | 30 | 3.0 | 3.0 |
| Riociguat | 14 | 2.9 | 2.9 |